Filling the need for trusted information on national health issues…

Trending on kff Ebola Marketplaces Consumer Resources

Private Sector Involvement

  • your selections
Clear Search

Filter Results

date

Tags

  • results
Indian Government Rejects Abbott’s Patent Application For Second-Line ARV

India’s patent office “has rejected American drug maker Abbott Laboratories’ patent application for an HIV combination drug, allowing low-cost local drug makers to make and sell their generic versions in India and other countries where the medicine is not patented,” Economic Times reports (1/4). The drug under consideration was Abbott’s “Kaletra, which combines two antivirals, [lopinavir/ritonavir and] is one of the preferred second-line treatments to fight drug-resistant HIV, according to the World Health Organization, which recommends governments include it on their list of essential medicines,” Bloomberg/Businessweek writes (Narayan, 1/4).

Newsweek Reports On Growth Of Safety Net Programs In Developing Countries

“[A] recent study by the World Health Organization and the International Labor Organization identified 72 different ‘social pension’ plans around the world dedicated to the elderly, the ill, or the down and out,” Newsweek writes in an article exploring the growth in welfare programs around the world. “Most countries on the [WHO/ILO] list are developing nations once considered too destitute to help their poor and that, until recently, had little or no welfare coverage at all. … While fighting inequality and helping the neediest has long been on the docket of Third World leaders, most previous attempts have been sabotaged by inefficiency, corruption, and stagnant or dysfunctional economies,” the magazine writes. “Now roaring economies in Asia, Latin America, and even Africa, coupled with better-functioning governments and sound fiscal stewardship, have stretched the policy horizons for many nations that once lived from one crisis to the next,” according to Newsweek.

The Scientist Examines How Nonprofit, For-Profit Pharma Groups Are Working Together To Make Drugs More Affordable For Developing Countries

“With philanthropists funneling billions of dollars into biomedical research and traditional drug discovery efforts producing fewer and fewer therapies, the line between for-profit and nonprofit life science companies is beginning to blur as both sides of the divide look for new options,” The Scientist magazine writes in an article that examines the rise in collaborations between nonprofit pharmaceutical companies and for-profit groups. “More and more for-profit enterprises are experimenting with nonprofit models, while nonprofit organizations look to incorporate for-profit business practices to stay afloat.”

Also In Global Health News: Disabled People And HIV; HIV/AIDS In Cambodia; South Africa Global Fund Grant; Early Marriage In Zambia; Indian Health Deal In Rwanda

U.N. Agencies’ Efforts To Combat HIV/AIDS Among Disabled People Examined IRIN PlusNews reports on different efforts aimed at addressing HIV/AIDS among people living with disabilities. “More than 600 million people – 10 percent of the global population – live with disabilities, and 80 percent of them live in developing countries. This population often…

Also In Global Health News: Reducing Violence Against Women; Bartering For Medical Care In Zimbabwe; Guinea Worm Eradication; Childhood Vaccination Successes, Challenges

AOL News Examines Fight Against Domestic Violence, Private Sector Role AOL News examines how the U.N. is working to include corporations in the effort to reduce domestic violence against women, which “includes beatings, rape, human trafficking and female genital mutilation.” According to the article, “more than 100 countries still don’t have laws against domestic…

Recent Releases In Global Health

Here is a sampling of blog posts analyzing the  Quadrennial Diplomacy and Development Review (QDDR) after it was released on Wednesday: Council on Foreign Relations: Weighing an Ambitious QDDR (Garrett et al., 12/16); CGD’s “Rethinking U.S. Foreign Assistance Blog”: The QDDR: Whew, It’s Done (Or Is It?) (Veillette, 12/16); State Department’s…

Also In Global Health News: Malaria Vaccine; Brazil’s Progress Toward MDGs; Malnutrition In Guatemala; Treatments For Kala-Azar

PATH, Merck, NYU To Work Together On Development Of Vaccine To Keep Malaria Parasite From Entering Liver The PATH Malaria Vaccine Initiative (MVI), pharmaceutical company Merck and New York University’s Langone Medical Center on Tuesday announced they were collaborating “to develop a vaccine capable of preventing the malaria parasite from…

Reuters Examines Investors’ Interests In Bonds That Support GAVI Alliance

“It’s not only biologists, philanthropists and donor governments who are needed to make vaccine projects in poor countries work. Financial engineers … also have a role,” Reuters writes in an article that examines how “a new kind of bond issue” is helping to support the GAVI Alliance.